Early research in the last 50 years led to the development of Lipastabil, a product that treated angina and was accepted in 53 countries worldwide but disappeared after the manufacturer went low on funds. Nonetheless, this was primarily because research on phospholipids and their role in the cell membrane dwindled, and angioplasty and bypass surgeries became the mainstream solution. This was until a decade ago when Plaquex therapy came into play.
Plaquex is a composition of phospholipids extracted from soybeans. Recent findings show that it can treat atherosclerosis and has a unique ability to reduce fatty plaque deposits in artery walls. In addition, it lowers homocysteine and cholesterol concentrations, which increases life expectancy to 36 percent. This lipid therapy makes the heart withstand stress especially for individuals with a history of heart attacks and other heart-related injuries. Chelation therapy addresses calcium deposit but to lower cholesterol, plaquex therapy comes in handy. LDL cholesterol also referred to as “bad cholesterol blocks arteries and “good” or HDL cholesterol reverses this negative effect using phosphatidyl choline, which is also referred to as plaquex. However, it is of the essence to understand that chelation therapy does not act as a substitute for plaquex therapy but forms part of the treatment plan for the condition. Also, this does not mean that both therapies are administered at the same time but rather, at different treatment days.
Chelation therapy removes toxic heavy metals such as Lead, Cadmium or Mercury, but plaquex therapy creates surrogate HDL cholestorol and uses it to reverse the transportation of LDL cholesterol. This ensures that excess LDL cholesterol is removed and high atherogenic lipoprotein levels are reduced. In addition, chelation therapy can only be used when there is a deficiency in kidney functions whereas plaquex therapy not only stabilizes kidney functions but also reverses bad cholesterol accumulation.
European researchers have come to the conclusion that plaquex therapy can be used to treat:
- damaged heart muscles
- reduce angina pectoris
- improve sexual potency
- reduce homocysteine levels
- lower LDL cholesterol
- build up kidney function
- increase HDL cholesterol levels
- enhance memory and mental function
- lower hypertension
- improve walking distance in Peripheral Vascular Disease (PVD)
Plaquex therapy is given as an intravenous infusion, which lasts up to 120 minutes. This therapy cannot be mixed with EDTA chelation, which means other chelating agents such as vitamins, minerals or medical Ozone are used as substitutes but administered as a single unit. However, plaquex therapy is a stand-alone treatment for improving memory and kidney function and lowering LDL cholesterol in the blood. The procedure is also used in treating degenerative vascular diseases as part of an integrative therapy with EDTA chelation, Orthomolecular procedures, and Bio-Oxidation treatments.